FDA green-lights Zyn nicotine pouches

Published



The Food and Drug Administration on Thursday cleared the most popular nicotine pouch in the United States to stay on the market after the product proved to be a safer alternative for adults who smoke cigarettes, saying the benefits outweigh the possible risks to young people.

The agency said Philip Morris International’s Zyn pouches carry a lower risk for cancer and other serious health conditions than traditional dipping tobacco or cigarettes.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.